Aerosol protection using modified N95 respirator for upper gastrointestinal endoscopy: A randomized control trial

Phase 1

• Conditions: Patients receiving upper gastrointestinal endoscopy; Upper gastrointestinal endoscopy, N95, Particle count, Aerosol

• Registration Number: TCTR20220121006
• Lead Sponsor: Siriraj hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-01-21
• Study Completion: 2022-05-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Patients receiving upper gastrointestinal endoscopy with negative result of RT-PCR for COVID-19 within 48 hours prior to procedure

Exclusion Criteria

Requiring general anesthesia with endotracheal intubation, Transnasal upper gastrointestinal endoscopy, Transnasal endoscopic procedure or feeding tube insertion, Out of the scope therapeutic procedure (e.g. Dilation with Savary-Gillard), Previous upper gastrointestinal tract surgery

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Particle count after finish procedure TSI aerotrak handheld particle

Secondary Outcome Measures

Name	Time	Method
Particle size after finish procedure TSI aerotrak handheld particle,Duration of procedure after finish procedure minutes